Report cover image

Global Alternative to Antibiotics Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 122 Pages
SKU # APRC20354829

Description

Summary

According to APO Research, The global Alternative to Antibiotics market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Alternative to Antibiotics include DSM, BioGaia, Bioriginal, Biosearch Life, China-Biotics, Chr. Hansen, Danone, DuPont(Danisco) and Ganeden, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alternative to Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alternative to Antibiotics.

The Alternative to Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alternative to Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Alternative to Antibiotics Segment by Company

DSM
BioGaia
Bioriginal
Biosearch Life
China-Biotics
Chr. Hansen
Danone
DuPont(Danisco)
Ganeden
Glory Biotech
Greentech
Lallemand
Morinaga Milk Industry
Novozymes
Probi
Sabinsa
Synbiotech
UAS Laboratories
Valio
Yakult
Nestle

Alternative to Antibiotics Segment by Type

Antimicrobial Proteins
Bacteriophages
Probiotics
Other

Alternative to Antibiotics Segment by Application

Drugs
Food & Beverage
Dietary Supplements

Alternative to Antibiotics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alternative to Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alternative to Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alternative to Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alternative to Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Alternative to Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

122 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Alternative to Antibiotics Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Alternative to Antibiotics Sales Estimates and Forecasts (2020-2031)
1.3 Alternative to Antibiotics Market by Type
1.3.1 Antimicrobial Proteins
1.3.2 Bacteriophages
1.3.3 Probiotics
1.3.4 Other
1.4 Global Alternative to Antibiotics Market Size by Type
1.4.1 Global Alternative to Antibiotics Market Size Overview by Type (2020-2031)
1.4.2 Global Alternative to Antibiotics Historic Market Size Review by Type (2020-2025)
1.4.3 Global Alternative to Antibiotics Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Alternative to Antibiotics Sales Breakdown by Type (2020-2025)
1.5.2 Europe Alternative to Antibiotics Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Alternative to Antibiotics Sales Breakdown by Type (2020-2025)
1.5.4 South America Alternative to Antibiotics Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Alternative to Antibiotics Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Alternative to Antibiotics Industry Trends
2.2 Alternative to Antibiotics Industry Drivers
2.3 Alternative to Antibiotics Industry Opportunities and Challenges
2.4 Alternative to Antibiotics Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Alternative to Antibiotics Revenue (2020-2025)
3.2 Global Top Players by Alternative to Antibiotics Sales (2020-2025)
3.3 Global Top Players by Alternative to Antibiotics Price (2020-2025)
3.4 Global Alternative to Antibiotics Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Alternative to Antibiotics Major Company Production Sites & Headquarters
3.6 Global Alternative to Antibiotics Company, Product Type & Application
3.7 Global Alternative to Antibiotics Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Alternative to Antibiotics Market CR5 and HHI
3.8.2 Global Top 5 and 10 Alternative to Antibiotics Players Market Share by Revenue in 2024
3.8.3 2023 Alternative to Antibiotics Tier 1, Tier 2, and Tier 3
4 Alternative to Antibiotics Regional Status and Outlook
4.1 Global Alternative to Antibiotics Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Alternative to Antibiotics Historic Market Size by Region
4.2.1 Global Alternative to Antibiotics Sales in Volume by Region (2020-2025)
4.2.2 Global Alternative to Antibiotics Sales in Value by Region (2020-2025)
4.2.3 Global Alternative to Antibiotics Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Alternative to Antibiotics Forecasted Market Size by Region
4.3.1 Global Alternative to Antibiotics Sales in Volume by Region (2026-2031)
4.3.2 Global Alternative to Antibiotics Sales in Value by Region (2026-2031)
4.3.3 Global Alternative to Antibiotics Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Alternative to Antibiotics by Application
5.1 Alternative to Antibiotics Market by Application
5.1.1 Drugs
5.1.2 Food & Beverage
5.1.3 Dietary Supplements
5.2 Global Alternative to Antibiotics Market Size by Application
5.2.1 Global Alternative to Antibiotics Market Size Overview by Application (2020-2031)
5.2.2 Global Alternative to Antibiotics Historic Market Size Review by Application (2020-2025)
5.2.3 Global Alternative to Antibiotics Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Alternative to Antibiotics Sales Breakdown by Application (2020-2025)
5.3.2 Europe Alternative to Antibiotics Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Alternative to Antibiotics Sales Breakdown by Application (2020-2025)
5.3.4 South America Alternative to Antibiotics Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Alternative to Antibiotics Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 DSM
6.1.1 DSM Comapny Information
6.1.2 DSM Business Overview
6.1.3 DSM Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 DSM Alternative to Antibiotics Product Portfolio
6.1.5 DSM Recent Developments
6.2 BioGaia
6.2.1 BioGaia Comapny Information
6.2.2 BioGaia Business Overview
6.2.3 BioGaia Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioGaia Alternative to Antibiotics Product Portfolio
6.2.5 BioGaia Recent Developments
6.3 Bioriginal
6.3.1 Bioriginal Comapny Information
6.3.2 Bioriginal Business Overview
6.3.3 Bioriginal Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bioriginal Alternative to Antibiotics Product Portfolio
6.3.5 Bioriginal Recent Developments
6.4 Biosearch Life
6.4.1 Biosearch Life Comapny Information
6.4.2 Biosearch Life Business Overview
6.4.3 Biosearch Life Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biosearch Life Alternative to Antibiotics Product Portfolio
6.4.5 Biosearch Life Recent Developments
6.5 China-Biotics
6.5.1 China-Biotics Comapny Information
6.5.2 China-Biotics Business Overview
6.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 China-Biotics Alternative to Antibiotics Product Portfolio
6.5.5 China-Biotics Recent Developments
6.6 Chr. Hansen
6.6.1 Chr. Hansen Comapny Information
6.6.2 Chr. Hansen Business Overview
6.6.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Chr. Hansen Alternative to Antibiotics Product Portfolio
6.6.5 Chr. Hansen Recent Developments
6.7 Danone
6.7.1 Danone Comapny Information
6.7.2 Danone Business Overview
6.7.3 Danone Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Danone Alternative to Antibiotics Product Portfolio
6.7.5 Danone Recent Developments
6.8 DuPont(Danisco)
6.8.1 DuPont(Danisco) Comapny Information
6.8.2 DuPont(Danisco) Business Overview
6.8.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 DuPont(Danisco) Alternative to Antibiotics Product Portfolio
6.8.5 DuPont(Danisco) Recent Developments
6.9 Ganeden
6.9.1 Ganeden Comapny Information
6.9.2 Ganeden Business Overview
6.9.3 Ganeden Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ganeden Alternative to Antibiotics Product Portfolio
6.9.5 Ganeden Recent Developments
6.10 Glory Biotech
6.10.1 Glory Biotech Comapny Information
6.10.2 Glory Biotech Business Overview
6.10.3 Glory Biotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Glory Biotech Alternative to Antibiotics Product Portfolio
6.10.5 Glory Biotech Recent Developments
6.11 Greentech
6.11.1 Greentech Comapny Information
6.11.2 Greentech Business Overview
6.11.3 Greentech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Greentech Alternative to Antibiotics Product Portfolio
6.11.5 Greentech Recent Developments
6.12 Lallemand
6.12.1 Lallemand Comapny Information
6.12.2 Lallemand Business Overview
6.12.3 Lallemand Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lallemand Alternative to Antibiotics Product Portfolio
6.12.5 Lallemand Recent Developments
6.13 Morinaga Milk Industry
6.13.1 Morinaga Milk Industry Comapny Information
6.13.2 Morinaga Milk Industry Business Overview
6.13.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Morinaga Milk Industry Alternative to Antibiotics Product Portfolio
6.13.5 Morinaga Milk Industry Recent Developments
6.14 Novozymes
6.14.1 Novozymes Comapny Information
6.14.2 Novozymes Business Overview
6.14.3 Novozymes Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Novozymes Alternative to Antibiotics Product Portfolio
6.14.5 Novozymes Recent Developments
6.15 Probi
6.15.1 Probi Comapny Information
6.15.2 Probi Business Overview
6.15.3 Probi Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Probi Alternative to Antibiotics Product Portfolio
6.15.5 Probi Recent Developments
6.16 Sabinsa
6.16.1 Sabinsa Comapny Information
6.16.2 Sabinsa Business Overview
6.16.3 Sabinsa Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Sabinsa Alternative to Antibiotics Product Portfolio
6.16.5 Sabinsa Recent Developments
6.17 Synbiotech
6.17.1 Synbiotech Comapny Information
6.17.2 Synbiotech Business Overview
6.17.3 Synbiotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Synbiotech Alternative to Antibiotics Product Portfolio
6.17.5 Synbiotech Recent Developments
6.18 UAS Laboratories
6.18.1 UAS Laboratories Comapny Information
6.18.2 UAS Laboratories Business Overview
6.18.3 UAS Laboratories Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.18.4 UAS Laboratories Alternative to Antibiotics Product Portfolio
6.18.5 UAS Laboratories Recent Developments
6.19 Valio
6.19.1 Valio Comapny Information
6.19.2 Valio Business Overview
6.19.3 Valio Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Valio Alternative to Antibiotics Product Portfolio
6.19.5 Valio Recent Developments
6.20 Yakult
6.20.1 Yakult Comapny Information
6.20.2 Yakult Business Overview
6.20.3 Yakult Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Yakult Alternative to Antibiotics Product Portfolio
6.20.5 Yakult Recent Developments
6.21 Nestle
6.21.1 Nestle Comapny Information
6.21.2 Nestle Business Overview
6.21.3 Nestle Alternative to Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Nestle Alternative to Antibiotics Product Portfolio
6.21.5 Nestle Recent Developments
7 North America by Country
7.1 North America Alternative to Antibiotics Sales by Country
7.1.1 North America Alternative to Antibiotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Alternative to Antibiotics Sales by Country (2020-2025)
7.1.3 North America Alternative to Antibiotics Sales Forecast by Country (2026-2031)
7.2 North America Alternative to Antibiotics Market Size by Country
7.2.1 North America Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Alternative to Antibiotics Market Size by Country (2020-2025)
7.2.3 North America Alternative to Antibiotics Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Alternative to Antibiotics Sales by Country
8.1.1 Europe Alternative to Antibiotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Alternative to Antibiotics Sales by Country (2020-2025)
8.1.3 Europe Alternative to Antibiotics Sales Forecast by Country (2026-2031)
8.2 Europe Alternative to Antibiotics Market Size by Country
8.2.1 Europe Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Alternative to Antibiotics Market Size by Country (2020-2025)
8.2.3 Europe Alternative to Antibiotics Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Alternative to Antibiotics Sales by Country
9.1.1 Asia-Pacific Alternative to Antibiotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Alternative to Antibiotics Sales by Country (2020-2025)
9.1.3 Asia-Pacific Alternative to Antibiotics Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Alternative to Antibiotics Market Size by Country
9.2.1 Asia-Pacific Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Alternative to Antibiotics Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Alternative to Antibiotics Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Alternative to Antibiotics Sales by Country
10.1.1 South America Alternative to Antibiotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Alternative to Antibiotics Sales by Country (2020-2025)
10.1.3 South America Alternative to Antibiotics Sales Forecast by Country (2026-2031)
10.2 South America Alternative to Antibiotics Market Size by Country
10.2.1 South America Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Alternative to Antibiotics Market Size by Country (2020-2025)
10.2.3 South America Alternative to Antibiotics Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Alternative to Antibiotics Sales by Country
11.1.1 Middle East and Africa Alternative to Antibiotics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Alternative to Antibiotics Sales by Country (2020-2025)
11.1.3 Middle East and Africa Alternative to Antibiotics Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Alternative to Antibiotics Market Size by Country
11.2.1 Middle East and Africa Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Alternative to Antibiotics Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Alternative to Antibiotics Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Alternative to Antibiotics Value Chain Analysis
12.1.1 Alternative to Antibiotics Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Alternative to Antibiotics Production Mode & Process
12.2 Alternative to Antibiotics Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Alternative to Antibiotics Distributors
12.2.3 Alternative to Antibiotics Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.